This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Prioritizing financial planning is essential for young people aiming to build wealth. Learn the reasons to start your financial journey today.
27,102 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Celsius is already generating strong margins, and that has investors rethinking how high profits could go. This artic...
Nuscale Power stock rocketing headlines point to optimism around small modular reactors, policy momentum, and utility...
SpaceX is pursuing a bold mix of rockets, Starlink, and AI infrastructure. Yet heavy capital needs and a large debt l...
Gold rise again has investors looking for tangible exposure to rising prices. This article breaks down two solid mini...
A major insider sale at TransMedics grabbed attention after the stock slumped about 45%. This article dives into what...
Sandisk stock bounced back today as traders weighed memory price signals and broader tech trends. This guide breaks d...
A major fund trimmed a sizable stake in Manhattan Associates as the stock pulled back sharply. This article breaks do...
This in-depth analysis explores what could drive ASML stock in 2026, with practical scenarios, risk factors, and clea...
A pullback in AbbVie has some investors asking if the stock looks like a bargain. This guide explains why that view m...
Rare earths power the tech and defense backbone of modern economies. This guide explains how to identify your favorit...
When memory and storage costs rise, Apple often responds with price shifts. This article explains how those moves aff...